AEON Biopharma Inc (AMEX:AEON) concluded the trading at $0.12 on Wednesday, February 19 with a rise of 5.50% from its closing price on previous day.
Considering stock’s 52-week price range provides that AEON hit a high price of $17.17 and saw its price falling to a low level of $0.10 during that period. Over a period of past 1-month, stock came subtracting -25.32% in its value.
With its current market valuation of $9.20 million, AEON Biopharma Inc is set to declare its quarterly results in March. Analysts are in estimates of 0 per share for company’s earnings in the current quarter and are expecting its annual EPS growth moving up to 0 for current year with estimates of that growing to 0 in next year.
In contrast, when we review AEON stock’s current outlook then short term indicators are assigning it an average of 100% Sell, while medium term indicators are categorizing the stock at an average of 100% Sell. Long term indicators are suggesting an average of 100% Sell for it.
According to ratings assigned by 1 analysts at the scale of 1 to 5 with 1.00 representing a strong buy and 5.00 suggesting a strong sell; 0 of them are recommending AEON Biopharma Inc (AEON) as a Hold, while 1 are in view that stock is a Buy. Recommendation by 0 analysts for the stock is an Underweight while number of those analysts who rated the stock as an Overweight is 0, whereas 0 of them are considering the stock as a Sell. When taken as whole, stock gets a rating of Overweight and that encourages the investors to exploit the opportunity and build their stake up in the company.
Digging deeper we become aware of the PEG ratio of the AEON stock which is currently positioned at 0. It further provides that stock’s current price level is -9.67% away from its 20-day simple moving average and is -65.96% off its SMA50. Its relative strength index (RSI) for 14-periods is oscillating at 31.44 while volatility remained at 10.70% over the past week which changes to 10.90% when measuring it over the past month. Beta is valued at 0.05, while measure of average true range or ATR is currently at 0.03.
The percentage of outstanding shares held by the insiders is 40.58% while it is 24.99% for the institutional holders. Subtraction of -78.70% by stock’s current price to its year-to-date value in last trading session is likely to be increasing investors’ interest in the stock as it is hinting an extended uptrend.
